Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Thorax
|
April 19, 2014
Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
Michelle T Harrison, Philip Short, Peter A Williamson, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT
Graham Devereux, Seonaidh Cotton, Mintu Nath, et al.
JAMA
|
May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial
Graham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Trials
|
April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Thorax
|
May 8, 2026
Impact of a national mesothelioma network on outcomes including survival
Matthew Tate, Joshua Joseph Roche, Selina Tsim, et al.
BMJ Open Respiratory Research
|
July 1, 2026
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS)
Mark D J Neilly, Alexandrea MacPherson, Laura Alexander, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Thorax
|
April 19, 2014
Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy?
Michelle T Harrison, Philip Short, Peter A Williamson, et al.
Health Technology Assessment (Winchester, England)
|
May 19, 2025
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT
Graham Devereux, Seonaidh Cotton, Mintu Nath, et al.
JAMA
|
May 19, 2024
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial
Graham Devereux, Seonaidh Cotton, Mintu Nath, et al.
Trials
|
April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Thorax
|
May 8, 2026
Impact of a national mesothelioma network on outcomes including survival
Matthew Tate, Joshua Joseph Roche, Selina Tsim, et al.
BMJ Open Respiratory Research
|
July 1, 2026
Protocol for Mesothelioma Observational study of Risk prediction and Generation of paired benign-meso tissue samples, Including a Nested MRI Substudy (Meso-ORIGINS)
Mark D J Neilly, Alexandrea MacPherson, Laura Alexander, et al.
Page
of 2